175 related articles for article (PubMed ID: 10945016)
1. [Tumor microcirculation and selective enhancement of drug delivery--clinical applications based on pathophysiological experiments].
Sato H; Hori K; Sugiyama K; Tanda S; Sato Y
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1191-200. PubMed ID: 10945016
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels].
Wakui A; Sato H
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):741-9. PubMed ID: 6424580
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapeutic effect on metastatic tumors].
Takahashi H; Sato H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1255-9. PubMed ID: 2499264
[TBL] [Abstract][Full Text] [Related]
4. [Randomized controlled trial of induced hypertension chemotherapy (IHC) using angiotensin II human (TY-10721) in advanced gastric carcinoma (TY-10721 IHC Study Group Report)].
Sato H; Wakui A; Hoshi M; Kurihara M; Yokoyama M; Shimizu H
Gan To Kagaku Ryoho; 1991 Mar; 18(3):451-60. PubMed ID: 1900686
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative role of angiotensin II induced hypertension chemotherapy (IHC) in advanced gastric carcinoma].
Sugiyama K; Sato H; Ishizuka K; Hoshi M; Urushiyama M; Wakui A
Gan To Kagaku Ryoho; 1992 Feb; 19(2):203-9. PubMed ID: 1736832
[TBL] [Abstract][Full Text] [Related]
6. [Dose intensity and clinical response in patients with advanced gastric carcinoma treated by induced hypertension chemotherapy].
Sato H; Urushiyama M; Sugiyama K; Ishizuka K; Hoshi M; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):564-9. PubMed ID: 2321982
[TBL] [Abstract][Full Text] [Related]
7. [Cancer chemotherapy in combination with angiotensin-induced hypertension].
Wakui A; Suzuki M
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1577-83. PubMed ID: 6409008
[TBL] [Abstract][Full Text] [Related]
8. [Increase in tumor microvascular pressure by angiotensin-induced hypertension: implication for pharmacokinetic analysis of drug delivery into tumor tissue].
Hori K; Suzuki M; Abe I; Saito S; Sato H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):953-60. PubMed ID: 6870292
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging.
Sato H; Sugiyama K; Hoshi M; Urushiyama M; Ishizuka K
World J Surg; 1995; 19(6):836-42. PubMed ID: 8553675
[TBL] [Abstract][Full Text] [Related]
10. [Increase of blood flow in human tumor tissue under angiotensin II-induced hypertension].
Hoshi M; Sato H; Urushiyama M; Sugiyama K; Wakui A
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):978-86. PubMed ID: 3566299
[TBL] [Abstract][Full Text] [Related]
11. [Functional characterization of microcirculation in tumors: chemotherapeutic implications].
Suzuki M; Hori K; Abe I; Saito S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):751-6. PubMed ID: 3985643
[TBL] [Abstract][Full Text] [Related]
12. [Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel].
Sato T; Katsumi S; Murai T; Kawaguchi T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1915-21. PubMed ID: 3931558
[TBL] [Abstract][Full Text] [Related]
13. [Intrahepatic arterial infusion chemotherapy with angiotensin II for liver metastasis from gastric cancer].
Iwasaki Y; Kitamura M; Arai K
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1412-5. PubMed ID: 9703841
[TBL] [Abstract][Full Text] [Related]
14. Functional characteristics of tumor vessels: selective increase in tumor blood flow.
Suzuki M; Hori K; Saito S; Tanda S; Abe I; Sato H; Sato H
Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):37-45. PubMed ID: 2640066
[TBL] [Abstract][Full Text] [Related]
15. [Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Uozumi T
No To Shinkei; 1991 Jul; 43(7):657-62. PubMed ID: 1910950
[TBL] [Abstract][Full Text] [Related]
16. A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.
Suzuki M; Hori K; Abe I; Saito S; Sato H
J Natl Cancer Inst; 1981 Sep; 67(3):663-9. PubMed ID: 6944536
[TBL] [Abstract][Full Text] [Related]
17. [A new drug delivery system in metastatic foci of cancer].
Suzuki M; Hori K; Saito S; Tanda S; Li YL; Zhang QH; Abe I
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1219-22. PubMed ID: 2730021
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of chemotherapy under angiotensin II-induced hypertension in patients with advanced cancer.
Yamaue H; Tanimura H; Terashita S; Iwahashi M; Tani M; Tsunoda T; Tamai M; Mori K
Nihon Geka Hokan; 1990 Jul; 59(4):302-9. PubMed ID: 2130794
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement of vascular level in tumors under angiotensin-induced hypertension].
Hori K; Suzuki M; Abe I; Saito S
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1323-30. PubMed ID: 4004292
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
